Research output per year
Research output per year
Fingerprint
Dive into the research topics where IM-Hem Onc Kidney is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types
Bex, A., Jewett, M., Lewis, B., Abel, E. J., Albiges, L., Berg, S. A., Bratslavsky, G., Braun, D., Brugarolas, J., Choueiri, T. K., Finelli, A., George, D., Haas, N. B., Hakimi, A. A., Hammers, H., Hirsch, M., Jonasch, E., Kapur, P., Linehan, W. M. & Master, V. & 15 others, , Apr 2025, In: European urology. 87, 4, p. 385-389 5 p.Research output: Contribution to journal › Editorial › peer-review
2 Scopus citations -
Acquired resistance to immune checkpoint therapy is caused by glycoprotein non-metastatic melanoma protein B signal cascade
Chung, J.-S., Ramani, V., Guo, L., Popat, V., Cruz, P. D., Xu, L., Hammers, H. & Ariizumi, K., Dec 2025, In: Communications Medicine. 5, 1, 79.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Systemic Treatment of Locally Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
Vento, J. A., Zhang, T., Kapur, P., Hammers, H., Brugarolas, J. & Qin, Q., May 2025, In: Cancers. 17, 9, 1527.Research output: Contribution to journal › Review article › peer-review